Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection

The time passed since the infection of a human immunodeficiency virus (HIV)-infected individual (the age of infection) is an important but often only poorly known quantity. We assessed whether the fraction of ambiguous nucleotides obtained from bulk sequencing as done for genotypic resistance testing can serve as a proxy of this parameter.

Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared

BACKGROUND: The provision of highly active antiretroviral therapy (HAART) in resource-limited settings follows a public health approach, which is characterised by a limited number of regimens and the standardisation of clinical and laboratory monitoring. In industrialized countries doctors prescribe from the full range of available antiretroviral drugs, supported by resistance testing and frequent laboratory monitoring. We compared virologic response, changes to first-line regimens, and mortality in HIV-infected patients starting HAART in South Africa and Switzerland. METHODS AND FINDINGS: We analysed data from the Swiss HIV Cohort Study and two HAART programmes in townships of Cape Town, South Africa. We included treatment-naïve patients aged 16 y or older who had started treatment with at least three drugs since 2001, and excluded intravenous drug users. Data from a total of 2,348 patients from South Africa and 1,016 patients from the Swiss HIV Cohort Study were analysed. Median baseline CD4+ T cell counts were 80 cells/mul in South Africa and 204 cells/mul in Switzerland. In South Africa, patients started with one of four first-line regimens, which was subsequently changed in 514 patients (22%). In Switzerland, 36 first-line regimens were used initially, and these were changed in 539 patients (53%). In most patients HIV-1 RNA was suppressed to 500 copies/ml or less within one year: 96% (95% confidence interval [CI] 95%-97%) in South Africa and 96% (94%-97%) in Switzerland, and 26% (22%-29%) and 27% (24%-31%), respectively, developed viral rebound within two years. Mortality was higher in South Africa than in Switzerland during the first months of HAART: adjusted hazard ratios were 5.90 (95% CI 1.81-19.2) during months 1-3 and 1.77 (0.90-3.50) during months 4-24. CONCLUSIONS: Compared to the highly individualised approach in Switzerland, programmatic HAART in South Africa resulted in similar virologic outcomes, with relatively few changes to initial regimens. Further innovation and resources are required in South Africa to both achieve more timely access to HAART and improve the prognosis of patients who start HAART with advanced disease.

A low affinity penicillin-binding protein 2x is required for heteroresistance in Streptococcus pneumoniae

Heteroresistance to penicillin in Streptococcus pneumoniae is the ability of subpopulations to grow at a higher antibiotic concentration than expected from the minimal inhibitory concentration (MIC). This may render conventional resistance testing unreliable and lead to therapeutic failure. We investigated the role of the primary β-lactam resistance determinants, penicillin binding proteins PBP2b and PBP2x and secondary resistance determinant PBP1a in heteroresistance to penicillin. Transformants containing PBP genes from heteroresistant strain Spain(23F)2349 in non-heteroresistant strain R6 background were tested for heteroresistance by population analysis profiling (PAP). We found that pbp2x, but not pbp2b or pbp1a alone, conferred heteroresistance to R6. However, a change of pbp2x expression is not observed and therefore expression does not correlate with an increased proportion of resistant subpopulations. Additional ciaR disruption mutants which have been described to mediate PBP-independent β-lactam resistance revealed no heteroresistant phenotype by PAP.We also showed, that the highly resistant subpopulations (HOM*) of transformants containing low affinity pbp2x undergo an increase in resistance upon selection on penicillin plates which partially reverts after passaging on selection-free medium. Shotgun proteomic analysis showed an upregulation of phosphate ABC transporter subunit proteins pstS, phoU, pstB and pstC in these highly resistant subpopulations.In conclusion, the presence of low affinity pbp2x enables certain pneumococcal colonies to survive in the presence of beta lactams. Upregulation of phosphate ABC transporter genes may represent a reversible adaption to antibiotic stress.

[Nocardia cyriacigeorgici: First report of invasive human infection]

BACKGROUND Diagnostic laboratories increasingly offer bacterial identification to the species level. The 17 nocardia species known to date differ in their clinical presentation, antibiotic resistance patterns and geographic distribution. The discovery of a new species with pathogenicity for humans calls for the characterization of its clinical and epidemiological properties. PATIENTS AND METHODS Nocardia isolated from multifocal brain abscesses of an immunocompromised patient were further identified by the analysis of their cellular fatty acids and sequencing of the 16S ribosomal DNA. Quantitative antibiotic resistance testing was performed with E-tests. RESULTS The 16S ribosomal DNA analysis showed a 99 % homology to Nocardia cyriacigeorgici. This is the first report of this species as an invasive human pathogen. N. cyriacigeorgici was found susceptible for meropenem, amikacin, ceftriaxon and cotrimoxazole. The combination of surgical drainage and antibiotic treatment for 13 months was curative. CONCLUSIONS N. cyriacigeorgici has the potential to cause invasive infections at least in immunocompromised patients. Comparing clinical and in vitro characteristics with N. asteroides, the main causative agent of nocardial infections in Europe, we found no clinically relevant differences.

Viral escape in the CNS with multidrug-resistant HIV-1.

Introduction: HIV-1 viral escape in the cerebrospinal fluid (CSF) despite viral suppression in plasma is rare [1,2]. We describe the case of a 50-year-old HIV-1 infected patient who was diagnosed with HIV-1 in 1995. Antiretroviral therapy (ART) was started in 1998 with a CD4 T cell count of 71 cells/ìL and HIV-viremia of 46,000 copies/mL. ART with zidovudine (AZT), lamivudine (3TC) and efavirenz achieved full viral suppression. After the patient had interrupted ART for two years, treatment was re-introduced with tenofovir (TDF), emtricitabin (FTC) and ritonavir boosted atazanavir (ATVr). This regimen suppressed HIV-1 in plasma for nine years and CD4 cells stabilized around 600 cells/ìL. Since July 2013, the patient complained about severe gait ataxia and decreased concentration. Materials and Methods: Additionally to a neurological examination, two lumbar punctures, a cerebral MRI and a neuropsycological test were performed. HIV-1 viral load in plasma and in CSF was quantified using Cobas TaqMan HIV-1 version 2.0 (Cobas Ampliprep, Roche diagnostic, Basel, Switzerland) with a detection limit of 20 copies/mL. Drug resistance mutations in HIV-1 reverse transcriptase and protease were evaluated using bulk sequencing. Results: The CSF in January 2014 showed a pleocytosis with 75 cells/ìL (100% mononuclear) and 1,184 HIV-1 RNA copies/mL, while HIV-1 in plasma was below 20 copies/mL. The resistance testing of the CSF-HIV-1 RNA showed two NRTI resistance-associated mutations (M184V and K65R) and one NNRTI resistance-associated mutation (K103N). The cerebral MRI showed increased signal on T2-weighted images in the subcortical and periventricular white matter, in the basal ganglia and thalamus. Four months after ART intensification with AZT, 3TC, boosted darunavir and raltegravir, the pleocytosis in CSF cell count normalized to 1 cell/ìL and HIV viral load was suppressed. The neurological symptoms improved; however, equilibrium disturbances and impaired memory persisted. The neuro-psychological evaluation confirmed neurocognitive impairments in executive functions, attention, working and nonverbal memory, speed of information processing, visuospatial abilities and motor skills. Conclusions: HIV-1 infected patients with neurological complaints prompt further investigations of the CSF including measurement of HIV viral load and genotypic resistance testing since isolated replication of HIV with drug resistant variants can rarely occur despite viral suppression in plasma. Optimizing ART by using drugs with improved CNS penetration may achieve viral suppression in CSF with improvement of neurological symptoms.

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons

BACKGROUND Hepatitis B virus (HBV) genotypes can influence treatment outcome in HBV-monoinfected and human immunodeficiency virus (HIV)/HBV-coinfected patients. Tenofovir disoproxil fumarate (TDF) plays a pivotal role in antiretroviral therapy (ART) of HIV/HBV-coinfected patients. The influence of HBV genotypes on the response to antiviral drugs, particularly TDF, is poorly understood. METHODS HIV/HBV-co-infected participants with detectable HBV DNA prior to TDF therapy were selected from the Swiss HIV Cohort Study. HBV genotypes were identified and resistance testing was performed prior to antiviral therapy, and in patients with delayed treatment response (>6 months). The efficacy of TDF to suppress HBV (HBV DNA <20 IU/mL) and the influence of HBV genotypes were determined. RESULTS 143 HIV/HBV-coinfected participants with detectable HBV DNA were identified. The predominant HBV genotypes were A (82 patients, 57 %); and D (35 patients, 24 %); 20 patients (14 %) were infected with multiple genotypes (3 % A + D and 11 % A + G); and genotypes B, C and E were each present in two patients (1 %). TDF completely suppressed HBV DNA in 131 patients (92 %) within 6 months; and in 12 patients (8 %), HBV DNA suppression was delayed. No HBV resistance mutations to TDF were found in patients with delayed response, but all were infected with HBV genotype A (among these, 5 patients with genotype A + G), and all had previously been exposed to lamivudine. CONCLUSION In HIV/HBV-coinfected patients, infection with multiple HBV genotypes was more frequent than previously reported. The large majority of patients had an undetectable HBV viral load at six months of TDF-containing ART. In patients without viral suppression, no TDF-related resistance mutations were found. The role of specific genotypes and prior lamivudine treatment in the delayed response to TDF warrant further investigation.

Case-control study of factors associated with virologic failure in HIV-infected children on HAART in Botswana, a developing African country

According to the United Nations Program on HIV/AIDS (UNAIDS, 2008), in 2007 about 67 per cent of all HIV-infected patients in the world were in Sub-Saharan Africa, with 35% of new infections and 38% of the AIDS deaths occurring in Southern Africa. Globally, the number of children younger than 15 years of age infected with HIV increased from 1.6 million in 2001 to 2.0 million in 2007 and almost 90% of these were in Sub-Saharan Africa. (UNAIDS, 2008).^ Both clinical and laboratory monitoring of children on Highly Active Anti-Retroviral Therapy (HAART) are important and necessary to optimize outcomes. Laboratory monitoring of HIV viral load and genotype resistance testing, which are important in patient follow-up to optimize treatment success, are both generally expensive and beyond the healthcare budgets of most developing countries. This is especially true for the impoverished Sub-Saharan African nations. It is therefore important to identify those factors that are associated with virologic failure in HIV-infected Sub-Saharan African children. This will inform practitioners in these countries so that they can predict which patients are more likely to develop virologic failure and therefore target the limited laboratory monitoring budgets towards these at-risk patients. The objective of this study was to examine those factors that are associated with virologic failure in HIV-infected children taking Highly Active Anti-retroviral Therapy in Botswana, a developing Sub-Saharan African country. We examined these factors in a Case-Control study using medical records of HIV-infected children and adolescents on HAART at the Botswana-Baylor Children's Clinical Center of Excellence (BBCCCOE) in Gaborone, Botswana. Univariate and Multivariate Regression Analyses were performed to identify predictors of virologic failure in these children.^ The study population comprised of 197 cases (those with virologic failure) and 544 controls (those with virologic success) with ages ranging from 3 months to 16 years at baseline. Poor adherence (pill count <95% on at least 3 consecutive occasions) was the strongest independent predictor of virologic failure (adjusted OR = 269.97, 95% CI = 104.13 to 699.92; P < 0.001). Other independent predictors of virologic failure identified were: First Line NNRTI with Nevirapine (OR = 2.99, 95% CI = 1.19 to7.54; P = 0.020), Baseline HIV-1 Viral Load >750,000/ml (OR = 257, 95% CI = 1.47 to 8.63; P = 0.005), Positive History of PMTCT (OR = 11.65, 95% CI = 3.04-44.57; P < 0.001), Multiple Care-givers (>=3) (OR = 2.56, 95% CI = 1.06 to 6.19; P = 0.036) and Residence in a Village (OR = 2.85, 95% CI = 1.36 to 5.97; P = 0.005).^ The results of this study may help to improve virologic outcomes and reduce the costs of caring for HIV-infected children in resource-limited settings. ^ Keywords: Virologic Failure, Highly Active Anti-Retroviral Therapy, Sub-Saharan Africa, Children, Adherence.^

Comparison on the durability of different portland cements after five years exposure to sulfate and to sea water attack

Experimental research has been performed to relate specific cement characteristics to deterioration due to sulfate and sea water attack after five year exposure, and to study different test method suitability for sulfate and marine resistance. Sulfate resistance testing have been performed on mortar specimens made with fifteen cement types of statistically diverse chemical composition according to European standard EN 197-1, most of them with sulfate resistant properties according to Spanish regulations. Chemical and mechanical characteristics were studied to determine the variation in properties of selected cements. SO3 content, type and amount of additions, C3A, and C4AF content were used to examine relationships between these characteristics and the results of sulfate resistance. Mortar specimens testing using Na2SO4 as the aggressive medium according to ASTM 1012 (with w/c ratio adapted to prENV 196-X:1995) was performed using each type of cement; identical specimens were also stored in sea water, and in lime saturated water (blank condition), up to five year age. Additionally these cements were tested conforming ASTM 452 and Koch and Steinegger test. Recommended acceptance limits for sulfate resistance of cements concerning to each used test method were evaluated in order to explore their suitability. Relationships between cement characteristics, degradation, expansive products obtained by X-ray diffraction techniques and maximum expansion after applied storage treatments, were correlated at final age, to redefine cement characteristics for sulfate resistant and marine resistant Portland cement

Estudio sobre la durabilidad de los nuevos tipos de cemento para la evaluación del comportamiento de morteros y hormigones frente a la agresión química de los sulfatos y del agua de mar

Esta investigación ha sido desarrollada para analizar la influencia de las características específicas de los nuevos cementos en el comportamiento expansivo originado durante cinco años por el ataque externo por sulfatos o agua de mar, y para estudiar la validez de diversos métodos de ensayo aplicables para evaluar la resistencia de los conglomerantes a los sulfatos o al agua de mar. Se han determinado las características químicas y mecánicas de los quince cementos seleccionados en el estudio (su contenido de yeso, tipo y cantidad de adiciones, contenidos de C3A y C4AF) para examinar la relación entre estos parámetros y su durabilidad frente al ataque por sulfatos. Se han llevado a cabo ensayos para evaluar la resistencia a sulfatos sobre probetas de mortero fabricadas con los quince cementos comunes seleccionados de muy distintos tipos, la mayoría de ellos resistentes a sulfatos conforme a la norma UNE-EN 197-1. Por cada tipo de cemento se fabricaron probetas de mortero para la realización de ensayos acelerados usando Na2SO4 como medio agresivo según la norma ASTM C 1012 manteniendo esas condiciones de exposición durante dos años. En paralelo se fabricaron otras series de probetas idénticas, que fueron conservadas en agua de mar y en agua saturada en cal (como patrón de un medio no agresivo) durante el mismo plazo. Adicionalmente estos cementos fueron evaluados conforme a los procedimientos de ensayo acelerado de la norma ASTM C 452 y del ensayo de Koch y Steinegger. También se fabricaron otras series de probetas de 40x40x160 mm (adoptando una relación a/c=0,5 y la composición arena:cemento definida en la norma UNE-EN 196-1). Durante cinco años de exposición en las tres condiciones de conservación establecidas (sulfatos, agua de mar y agua patrón) se han efectuado ensayos para determinar la resistencia a compresión y el deterioro superficial de las probetas de mortero. Ninguno de los conglomerantes fue mezclado inicialmente con yeso para acelerar el ataque ni se establecieron otras condiciones no realísticas en la fabricación de los morteros Se ha analizado el comportamiento durable de los cementos tanto frente al ataque por sulfatos como por agua de mar. Para la evaluación se han tomado en consideración las variaciones de contenido en C3A, los tipos y proporciones de los constituyentes (adiciones puzolánicas, escorias de horno alto, caliza …) con el mismo tipo de clínker en algunos casos. Se ha procedido a evaluar la validez de los límites de aceptación establecidos en cada uno de los ensayos acelerados para determinar la resistencia a sulfatos y valorar su idoneidad en los nuevos cementos, y se ha propuesto un método de ensayo acelerado recomendable para discriminar cementos resistentes y no resistentes a sulfatos. A la edad final de los tres tipos de exposición han sido correlacionados los parámetros relativos a la degradación superficial, pérdida de resistencia y expansión lineal de las probetas con las características de los cementos y los productos expansivos analizados mediante difracción de rayos X, con objeto de poder redefinir las características recomendables exigibles a los cementos resistentes a sulfatos o al agua de mar. Experimental research has been performed to relate specific cement characteristics to expansion due to sulfate or sea water attack during five years, and to study different test methods suitability for sulfate and marine resistance. Chemical and mechanical characteristics were studied to determine the variation in properties of selected cements (SO3 content, type and amount of additions, C3A, and C4AF content) and examine relationships between these characteristics and the results of sulfate resistance. Sulfate resistance testing have been performed on mortar specimens prepared from fifteen cement types of statistically diverse chemical composition, most of them with sulfate resistant properties according to European standard EN 197-1 Mortar specimens testing using Na2SO4 as the aggressive medium according to ASTM C 1012 was performed using each cement; identical specimens were also stored in sea water, and in lime saturated water (blank condition), up to two years age. Additionally these cements were tested conforming to ASTM C 452 and Koch and Steinegger test. Mortar specimens of 40x40x160 mm were also moulded (with w/c ratio and cement:sand composition of EN 196-1). Compressive strength of these mortar specimens have been tested during five years of immersion in a sulfate solution and also in seawater (and in lime saturated water, as a blank condition), and external damage and have been analyzed. None of the prepared mortars was blended with gypsum or any other nonrealistic condition. Durability behaviour in sulfate resistant common cements conforming to EN 197-1 exposed to sulfate attack was evaluated, and also the correlation between sulfate resistance and seawater resistance has been studied. Different C3A contents, variable types and proportioning of constituents (limestone, pozzolanic additions, blastfurnace slag ...) with or without the same clinker type were investigated. Recommended acceptance limits for sulfate resistance of cements concerning to each used test method were evaluated in order to explore their suitability. A new accelerated method has been recommended to provide a meaningful discrimination between sulfate resistant or non-sulfate resistant cements. Relationships between cement characteristics, degradation, expansive products obtained by X-ray diffraction techniques, strength loss and maximum expansion after applied storage treatments, were correlated at final age, to redefine cement characteristics for sulfate resistant and marine resistant Portland cement.

Evaluation of galling resistance for some selected combinations of tool steels/stainless steel sheet materials/lubricants using pin-on-disc testing

Stainless steels are well known to be prone to cold welding and material transfer in sliding contacts and therefore difficult to cold form unless certain precautions as discussed in this paper are taken. In the present study different combinations of tool steels/stainless steels/lubricants has been evaluated with respect to their galling resistance using pin-on-disc testing. The results show that a high galling resistance is favored by a high stainless steel sheet hardness and a blasted stainless steel sheet surface topography. The effect of type of lubricant was found to be more complex. For example, the chlorinated lubricants failed to prevent metal-to-metal contact on a brushed sheet surface but succeeded on a blasted sheet surface of the same stainless steel material. This is believed to be due to a protective tribofilm which is able to form on the blasted surface, but not on the brushed surface.

Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results

Antiretroviral resistance mutations (ARM) are one of the major obstacles for pharmacological human immunodeficiency virus (HIV) suppression. Plasma HIV-1 RNA from 306 patients on antiretroviral therapy with virological failure was analyzed, most of them (60%) exposed to three or more regimens, and 28% of them have started therapy before 1997. The most common regimens in use at the time of genotype testing were AZT/3TC/nelfinavir, 3TC/D4T/nelfinavir and AZT/3TC/efavirenz. The majority of ARM occurred at protease (PR) gene at residue L90 (41%) and V82 (25%); at reverse transcriptase (RT) gene, mutations at residue M184 (V/I) were observed in 64%. One or more thymidine analogue mutations were detected in 73%. The number of ARM at PR gene increased from a mean of four mutations per patient who showed virological failure at the first ARV regimens to six mutations per patient exposed to six or more regimens; similar trend in RT was also observed. No differences in ARM at principal codon to the three drug classes for HIV-1 clades B or F were observed, but some polymorphisms in secondary codons showed significant differences. Strategies to improve the cost effectiveness of drug therapy and to optimize the sequencing and the rescue therapy are the major health priorities.